Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Genome-wide association study of patients with a severe major depressive episode treated with electroconvulsive therapy


Although large genome-wide association studies (GWAS) of major depressive disorder (MDD) have identified many significant loci, the SNP-based heritability remains notably low, which might be due to etiological heterogeneity in existing samples. Here, we test the utility of targeting the severe end of the MDD spectrum through genome-wide SNP genotyping of 2725 cases who received electroconvulsive therapy (ECT) for a major depressive episode (MDE) and 4035 controls. A subset of cases (n = 1796) met a narrow case definition (MDE occurring in the context of MDD). Standard GWAS quality control procedures and imputation were conducted. SNP heritability and genetic correlations with other traits were estimated using linkage disequilibrium score regression. Results were compared with MDD cases of mild-moderate severity receiving internet-based cognitive behavioral therapy (iCBT) and summary results from the Psychiatric Genomics Consortium (PGC). The SNP-based heritability was estimated at 29–34% (SE: 6%) for the narrow case definition, considerably higher than the 6.5–8.0% estimate in the most recent PGC MDD study. Our severe MDE cases had smaller genetic correlations with neurodevelopmental disorders and neuroticism than PGC MDD cases but higher genetic risk scores for bipolar disorder than iCBT MDD cases. One genome-wide significant locus was identified (rs114583506, P = 5e−8) in an intron of HLA-B in the major histocompatibility locus on chr6. These results indicate that individuals receiving ECT for an MDE have higher burden of common variant risk loci than individuals with mild-moderate MDD. Furthermore, severe MDE shows stronger relations with other severe adult-onset psychiatric disorders but weaker relations with personality and stress-related traits than mild-moderate MDD. These findings suggest a different genetic architecture at the severest end of the spectrum, and support further study of the severest MDD cases as an extreme phenotype approach to understand the etiology of MDD.

Your institute does not have access to this article

Relevant articles

Open Access articles citing this article.

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1: Genome-wide association results.
Fig. 2: Comparison of SNP-based heritability (h2) estimates and impact of population prevalence.
Fig. 3: Genetic correlations comparing a sample with severe major depressive episodes (green, mddnarrow, and blue, mddbroad PREFECT case definitions) to a large sample of more moderate cases (orange, mdd2019, Psychiatric Genomics Consortium—Major Depressive Disorder Working Group sample excluding 23andMe) on psychiatric, neurological, and central nervous system disorders along with other traits.
Fig. 4: Genetic risk scores (GRS) in severe ECT-treated major depressive disorder (MDD) cases (PREFECT MDD) compared with more mild/moderate internet-based cognitive behavioral therapy (iCBT) MDD cases.

Data availability

Summary statistics are available for download on the Psychiatric Genomic Consortium website.


  1. Hasin DS, Sarvet AL, Meyers JL, Saha TD, Ruan WJ, Stohl M, et al. Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States. JAMA Psychiatry. 2018;75:336–46.

    PubMed  PubMed Central  Article  Google Scholar 

  2. Ekman M, Granström O, Omerov S, Jacob J, Landen M. The societal cost of depression: evidence from 10,000 Swedish patients in psychiatric care. J Affect Disord. 2013;150:790–7.

    CAS  PubMed  Article  Google Scholar 

  3. Levinson DF, Mostafavi S, Milaneschi Y, Rivera M, Ripke S, Wray NR, et al. Genetic studies of major depressive disorder: why are there no genome-wide association study findings and what can we do about it? Biol Psychiatry. 2014;76:510–2.

    PubMed  PubMed Central  Article  Google Scholar 

  4. Sullivan PF, Neale MC, Kendler KS. Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry. 2000;157:1552–62.

    CAS  PubMed  Article  Google Scholar 

  5. Howard DM, Adams MJ, Clarke T-K, Hafferty JD, Gibson J, Shirali M, et al. Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions. Nat Neurosci. 2019;22:343–52.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  6. McIntosh AM, Sullivan PF, Lewis CM. Uncovering the genetic architecture of major depression. Neuron. 2019;102:91–103.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  7. Wray NR, Ripke S, Mattheisen M, Trzaskowski M, Byrne EM, Abdellaoui A, et al. Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. Nat Genet. 2018;50:668.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  8. Sullivan PF, Geschwind DH. Defining the genetic, genomic, cellular, and diagnostic architectures of psychiatric disorders. Cell. 2019;177:162–83.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  9. Hyde CL, Nagle MW, Tian C, Chen X, Paciga SA, Wendland JR, et al. Identification of 15 genetic loci associated with risk of major depression in individuals of European descent. Nat Genet. 2016;48:1031–6.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  10. Howard DM, Adams MJ, Shirali M, Clarke T-K, Marioni RE, Davies G, et al. Genome-wide association study of depression phenotypes in UK Biobank identifies variants in excitatory synaptic pathways. Nat Commun. 2018;16:1470.

    Article  CAS  Google Scholar 

  11. Cai N, Revez JA, Adams MJ, Andlauer TFM, Breen G, Byrne EM, et al. Minimal phenotyping yields genome-wide association signals of low specificity for major depression. Nat Genet. 2020;52:437–47.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  12. Guey LT, Kravic J, Melander O, Burtt NP, Laramie JM, Lyssenko V, et al. Power in the phenotypic extremes: a simulation study of power in discovery and replication of rare variants. Genet Epidemiol. 2011;35:236–46.

    PubMed  Google Scholar 

  13. Li D, Lewinger JP, Gauderman WJ, Murcray CE, Conti D. Using extreme phenotype sampling to identify the rare causal variants of quantitative traits in association studies. Genet Epidemiol. 2011;35:790–9.

    PubMed  PubMed Central  Article  Google Scholar 

  14. Brus O, Cao Y, Gustafsson E, Hultén M, Landen M, Lundberg J, et al. Self-assessed remission rates after electroconvulsive therapy of depressive disorders. Eur Psychiatry. 2017;45:154–60.

    CAS  PubMed  Article  Google Scholar 

  15. Nordenskjöld A, Knorring L, von, Engström I. Predictors of the short-term responder rate of electroconvulsive therapy in depressive disorders—a population based study. BMC Psychiatry. 2012;12:115.

    PubMed  PubMed Central  Article  Google Scholar 

  16. Carney S, Cowen P, Geddes J, Goodwin G, Rogers R, Dearness K, et al. Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet. 2003;361:799–808.

    Article  Google Scholar 

  17. Lisanby SH. Electroconvulsive therapy for depression. N Engl J Med. 2007;357:1939–45.

    CAS  PubMed  Article  Google Scholar 

  18. Pagnin D, de Queiroz V, Pini S, Cassano GB. Efficacy of ECT in depression: a meta-analytic review. J ECT. 2004;20:13.

    PubMed  Article  Google Scholar 

  19. Soda T, McLoughlin DM, Clark SR, Oltedal L, Kessler U, Haavik J, et al. International Consortium on the Genetics of Electroconvulsive Therapy and Severe Depressive Disorders (Gen-ECT-ic). Eur Arch Psychiatry Clin Neurosci. 2019.

  20. Zabaneh D, Krapohl E, Gaspar HA, Curtis C, Lee SH, Patel H, et al. A genome-wide association study for extremely high intelligence. Mol Psychiatry. 2018;23:1226–32.

    CAS  PubMed  Article  Google Scholar 

  21. Benyamin B, Pourcain BS, Davis OS, Davies G, Hansell NK, Brion M-JA, et al. Childhood intelligence is heritable, highly polygenic and associated with FNBP1L. Mol Psychiatry. 2014;19:253–8.

    CAS  PubMed  Article  Google Scholar 

  22. CONVERGE Consortium. Sparse whole-genome sequencing identifies two loci for major depressive disorder. Nature. 2015;523:588–91.

    PubMed Central  Article  CAS  Google Scholar 

  23. Nordenskjöld A. Kvalitetsregister ECT—Årsrapport 2014. Region Örebro län; Örebro, Sweden. 2014.

  24. Nordanskog P, Hultén M, Landén M, Lundberg J, von Knorring L, Nordenskjöld A. Electroconvulsive therapy in Sweden 2013: data From the National Quality Register for ECT. J ECT. 2015;31:263–7.

  25. Svanborg P, Åsberg M. A comparison between the Beck Depression Inventory (BDI) and the self-rating version of the Montgomery Åsberg Depression Rating Scale (MADRS). J Affect Disord. 2001;64:203–16.

    CAS  PubMed  Article  Google Scholar 

  26. Ahmad I. Validity of diagnoses and treatment dates in the Swedish National Quality Register for Electroconvulsive Therapy. Örebro: Örebro University; 2020.

  27. Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim J-L, Reuterwall C, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11:450.

    PubMed  PubMed Central  Article  Google Scholar 

  28. Ludvigsson JF, Svedberg P, Olén O, Bruze G, Neovius M. The longitudinal integrated database for health insurance and labour market studies (LISA) and its use in medical research. Eur J Epidemiol. 2019;34:423–37.

    PubMed  PubMed Central  Article  Google Scholar 

  29. Thornton LM, Munn-Chernoff MA, Baker JH, Juréus A, Parker R, Henders AK, et al. The Anorexia Nervosa Genetics Initiative (ANGI): overview and methods. Contemp Clin Trials. 2018;74:61–9.

    PubMed  PubMed Central  Article  Google Scholar 

  30. Watson HJ, Yilmaz Z, Thornton LM, Hübel C, Coleman JRI, Gaspar HA, et al. Genome-wide association study identifies eight risk loci and implicates metabo-psychiatric origins for anorexia nervosa. Nat Genet. 2019;51:1207–14.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  31. Almqvist C, Adami H-O, Franks PW, Groop L, Ingelsson E, Kere J, et al. LifeGene—a large prospective population-based study of global relevance. Eur J Epidemiol. 2011;26:67–77.

    PubMed  Article  Google Scholar 

  32. Andersson E, Crowley JJ, Lindefors N, Ljótsson B, Hedman-Lagerlöf E, Boberg J, et al. Genetics of response to cognitive behavior therapy in adults with major depression: a preliminary report. Mol Psychiatry. 2019;24:484–90.

    CAS  PubMed  Article  Google Scholar 

  33. Lam M, Awasthi S, Watson HJ, Goldstein J, Panagiotaropoulou G, Trubetskoy V, et al. RICOPILI: rapid imputation for COnsortias PIpeLIne. Bioinformatics. 2020;36:930–3.

    CAS  PubMed  Article  Google Scholar 

  34. McCarthy S, Das S, Kretzschmar W, Delaneau O, Wood AR, Teumer A, et al. A reference panel of 64,976 haplotypes for genotype imputation. Nat Genet. 2016;48:1279–83.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  35. Bulik-Sullivan BK, Loh P-R, Finucane HK, Ripke S, Yang J, Patterson N, et al. LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat Genet. 2015;47:291–5.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  36. Yang J, Lee SH, Goddard ME, Visscher PM. GCTA: a tool for genome-wide complex trait analysis. Am J Hum Genet. 2011;88:76–82.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  37. Stahl EA, Breen G, Forstner AJ, McQuillin A, Ripke S, Trubetskoy V, et al. Genome-wide association study identifies 30 loci associated with bipolar disorder. Nat Genet. 2019;51:793–803.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  38. Pardiñas AF, Holmans P, Pocklington AJ, Escott-Price V, Ripke S, Carrera N, et al. Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection. Nat Genet. 2018;50:381–9.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  39. Lee JJ, Wedow R, Okbay A, Kong E, Maghzian O, Zacher M, et al. Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals. Nat Genet. 2018;50:1112.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  40. Savage JE, Jansen PR, Stringer S, Watanabe K, Bryois J, de Leeuw CA, et al. Genome-wide association meta-analysis in 269,867 individuals identifies new genetic and functional links to intelligence. Nat Genet. 2018;50:912–9.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  41. Salk RH, Hyde JS, Abramson LY. Gender differences in depression in representative national samples: meta-analyses of diagnoses and symptoms. Psychol Bull. 2017;143:783–822.

    PubMed  PubMed Central  Article  Google Scholar 

  42. Viktorin A, Meltzer-Brody S, Kuja-Halkola R, Sullivan PF, Landén M, Lichtenstein P, et al. Heritability of perinatal depression and genetic overlap with nonperinatal depression. Am J Psychiatry. 2016;173:158–65.

    PubMed  Article  Google Scholar 

  43. Segerstrom SC, Tsao JCI, Alden LE, Craske MG. Worry and rumination: repetitive thought as a concomitant and predictor of negative mood. Cogn Ther Res. 2000;24:671–88.

    Article  Google Scholar 

  44. Coleman JRI, Gaspar HA, Bryois J, Bipolar Disorder Working Group of the Psychiatric Genomics Consortium, Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium, Breen G. The genetics of the mood disorder spectrum: genome-wide association analyses of more than 185,000 cases and 439,000 controls. Biol Psychiatry. 2020;88:169–84.

  45. Caspi A, Moffitt TE. All for one and one for all: mental disorders in one dimension. Am J Psychiatry. 2018;175:831–44.

    PubMed  PubMed Central  Article  Google Scholar 

  46. Brainstorm Consortium, Anttila V, Bulik-Sullivan B, Finucane HK, Walters RK, Bras J, et al. Analysis of shared heritability in common disorders of the brain. Science. 2018;360:eaap8757.

  47. Selzam S, Coleman JRI, Caspi A, Moffitt TE, Plomin R. A polygenic p factor for major psychiatric disorders. Transl Psychiatry. 2018;8:1–9.

    CAS  Article  Google Scholar 

  48. Nievergelt CM, Maihofer AX, Klengel T, Atkinson EG, Chen C-Y, Choi KW, et al. International meta-analysis of PTSD genome-wide association studies identifies sex- and ancestry-specific genetic risk loci. Nat Commun. 2019;10:4558.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  49. Khramtsova EA, Davis LK, Stranger BE. The role of sex in the genomics of human complex traits. Nat Rev Genet. 2019;20:173–90.

    CAS  PubMed  Article  Google Scholar 

Download references


We first thank the study participants. We also thank the staff at participating ECT-units in Danderyd, Huddinge, Hudiksvall, Sahlgrenska, Umeå, Uppsala, and Örebro for recruiting patients; the Swedish National Quality Register for ECT (Q-ECT) for providing data; and the and KI Biobank at Karolinska Institutet for professional biobank service. We thank PREFECT data collectors Marie Lundin, Birgitta Ohlander, Milka Krestelica, Radja Dawoud, Martina Wennberg, and PREFECT data manager Bozenna Illadou. The PREFECT study was funded by the Swedish foundation for Strategic Research (KF10-0039), and grants from the Swedish Research Council (2018-02653). PFS was supported by the Swedish Research Council (Vetenskapsrådet, award D0886501), the Horizon 2020 Program of the European Union (COSYN, RIA Grant Agreement No. 610307), and US NIMH (U01 MH109528 and R01 MH077139). CMB was supported by Swedish Research Council (Vetenskapsrådet, award: 538-2013-8864) and US NIMH (R01MH120170, R01MH119084, and U01 MH109528). CR was supported by the Swedish Research Council (2018-02487) and the Swedish Research Council for Health, Working Life and Welfare (2018-00221). CCC was supported by a US Fulbright grant. YL is in part supported by a 2018 NARSAD Young Investigator Grant from the Brain & Behaviour Research Foundation and US NIMH (R01 MH123724).

Author information

Authors and Affiliations


Corresponding authors

Correspondence to Patrick F. Sullivan or Mikael Landén.

Ethics declarations

Conflict of interest

ML declares that, over the past 36 months, he has received lecture honoraria from Lundbeck pharmaceutical. PFS reports the following potentially competing financial interests. Current: Lundbeck (advisory committee, grant recipient), RBNC Therapeutics (advisory committee, stock ownership). CMB reports: Shire (grant recipient, Scientific Advisory Board member); Idorsia (consultant); Pearson (author, royalty recipient). AJ is currently employed at the Swedish Medical Products Agency, SE-75103 Uppsala, Sweden. The views expressed in this paper are the personal views of the authors and not necessarily the views of the government agency. AJ’s contribution to this work was done before he started his employment at the MPA.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Clements, C.C., Karlsson, R., Lu, Y. et al. Genome-wide association study of patients with a severe major depressive episode treated with electroconvulsive therapy. Mol Psychiatry 26, 2429–2439 (2021).

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:

Further reading


Quick links